download - Dansk Kirurgisk Selskab

Referencer1. Schwartz DA, Loftus EV, Jr., Tremaine WJ et al. The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota.Gastroenterology 2002; 122:875-880.2. Lapidus A. Crohn's disease in Stockholm County during 1990-2001: an epidemiological update. World J Gastroenterol 2006;12:75-81.3. Tang LY, Rawsthorne P, Bernstein CN. Are perineal and luminal fistulas associated in Crohn's disease? A population-based study.Clin Gastroenterol Hepatol 2006; 4:1130-1134.4. Ingle SB, Loftus EV, Jr. The natural history of perianal Crohn's disease. Dig Liver Dis 2007; 39:963-969.5. Nielsen OH, Rogler G, Hahnloser D, Thomsen OO. Diagnosis and management of fistulizing Crohn's disease. Nat Clin PractGastroenterol Hepatol 2009; 6:92-106.6. Tottrup A, Basu D. Kirurgisk behandling af Crohns sygdom. Ugeskr Laeger 2004; 166:571-574.7. American Gastroenterological Association medical position statement: perianal Crohn's disease. Gastroenterology 2003;125:1503-1507.8. Present DH, Rutgeerts P, Targan S et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med1999; 340:1398-1405.9. Beckingham IJ, Spencer JA, Ward J et al. Prospective evaluation of dynamic contrast enhanced magnetic resonance imaging inthe evaluation of fistula in ano. Br J Surg 1996; 83:1396-1398.10. Beets-Tan RG, Beets GL, van der Hoop AG et al. Preoperative MR imaging of anal fistulas: Does it really help the surgeon?Radiology 2001; 218:75-84.11. Buchanan GN, Halligan S, Bartram CI et al. Clinical examination, endosonography, and MR imaging in preoperative assessment offistula in ano: comparison with outcome-based reference standard. Radiology 2004; 233:674-681.12. Schwartz DA, Wiersema MJ, Dudiak KM et al. A comparison of endoscopic ultrasound, magnetic resonance imaging, and examunder anesthesia for evaluation of Crohn's perianal fistulas. Gastroenterology 2001; 121:1064-1072.13. Irvine EJ. Usual therapy improves perianal Crohn's disease as measured by a new disease activity index. McMaster IBD StudyGroup. J Clin Gastroenterol 1995; 20:27-32.14. Sandborn WJ, Feagan BG, Hanauer SB et al. A review of activity indices and efficacy endpoints for clinical trials of medical therapyin adults with Crohn's disease. Gastroenterology 2002; 122:512-530.15. van Assche G, Dignass AU, Reinisch W et al. The second European evidence-based Consensus on the diagnosis andmanagement of Crohn's disease: Special situations. Journal of Crohn's and Colitis 2010; 4:63-101.16. Thia KT, Mahadevan U, Feagan BG et al. Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients withCrohn's disease: a randomized, double-blind, placebo-controlled pilot study. Inflamm Bowel Dis 2009; 15:17-24.17. Brandt LJ, Bernstein LH, Boley SJ, Frank MS. Metronidazole therapy for perineal Crohn's disease: a follow-up study.Gastroenterology 1982; 83:383-387.18. Jakobovits J, Schuster MM. Metronidazole therapy for Crohn's disease and associated fistulae. Am J Gastroenterol 1984; 79:533-540.19. Prantera C, Berto E, Scribano ML, Falasco G. Use of antibiotics in the treatment of active Crohn's disease: experience withmetronidazole and ciprofloxacin. Ital J Gastroenterol Hepatol 1998; 30:602-606.20. Bernstein LH, Frank MS, Brandt LJ, Boley SJ. Healing of perineal Crohn's disease with metronidazole. Gastroenterology 1980;79:599.21. Dejaco C, Harrer M, Waldhoer T et al. Antibiotics and azathioprine for the treatment of perianal fistulas in Crohn's disease. AlimentPharmacol Ther 2003; 18:1113-1120.22. Pearson DC, May GR, Fick GH, Sutherland LR. Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis. Ann InternMed 1995; 123:132-142.23. Sands BE, Anderson FH, Bernstein CN et al. Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med 2004;350:876-885.24. Behm BW, Bickston SJ. Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease. CochraneDatabase Syst Rev 2008;CD006893.25. Poritz LS, Rowe WA, Koltun WA. Remicade does not abolish the need for surgery in fistulizing Crohn's disease. Dis Colon Rectum2002; 45:771-775.26. Colombel JF, Schwartz DA, Sandborn WJ et al. Adalimumab for the treatment of fistulas in patients with Crohn's disease. Gut2009; 58:940-948.27. Lindsey I, Smilgin-Humphreys MM, Cunningham C, Mortensen NJ, George BD. A randomized, controlled trial of fibrin glue vs.conventional treatment for anal fistula. Dis Colon Rectum 2002; 45:1608-1615.28. O'Connor L, Champagne BJ, Ferguson MA et al. Efficacy of anal fistula plug in closure of Crohn's anorectal fistulas. Dis ColonRectum 2006; 49:1569-1573.29. Schwandner O, Stadler F, Dietl O, Wirsching RP, Fuerst A. Initial experience on efficacy in closure of cryptoglandular and Crohn'stranssphincteric fistulas by the use of the anal fistula plug. Int J Colorectal Dis 2008; 23:319-324.30. Ky AJ, Sylla P, Steinhagen R et al. Collagen fistula plug for the treatment of anal fistulas. Dis Colon Rectum 2008; 51:838-843.31. Poggioli G, Laureti S, Pierangeli F et al. Local injection of Infliximab for the treatment of perianal Crohn's disease. Dis ColonRectum 2005; 48:768-774.32. Asteria CR, Ficari F, Bagnoli S, Milla M, Tonelli F. Treatment of perianal fistulas in Crohn's disease by local injection of antibody toTNF-alpha accounts for a favourable clinical response in selected cases: a pilot study. Scand J Gastroenterol 2006; 41:1064-1072.33. Garcia-Olmo D, Herreros D, Pascual I et al. Expanded adipose-derived stem cells for the treatment of complex perianal fistula: aphase II clinical trial. Dis Colon Rectum 2009; 52:79-86.34. Regueiro M, Mardini H. Treatment of perianal fistulizing Crohn's disease with infliximab alone or as an adjunct to exam underanesthesia with seton placement. Inflamm Bowel Dis 2003; 9:98-103.35. Hyder SA, Travis SP, Jewell DP, McC Mortensen NJ, George BD. Fistulating anal Crohn's disease: results of combined surgicaland infliximab treatment. Dis Colon Rectum 2006; 49:1837-1841.7